Brainstorm Cell Therapeutics Inc.
BCLI- Exchange
- OTC
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001137883
No open-market purchases or sales by Brainstorm Cell Therapeutics Inc. insiders were filed in the last 90 days; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.
Q3 2024 vs. Q2 2024
How the institutions holding Brainstorm Cell Therapeutics Inc. changed between Q2 2024 and Q3 2024.
All holders in Q3 2024All holders in Q2 2024
| Measure | Q2 2024 | Of which not filed for Q3 2024 | Q3 2024 | Change |
|---|---|---|---|---|
| Holders | 48 | 2 | 38 | −8 |
| Shares | 12.2M | 392.4K | 11.0M | −859.5K (−7.3%) |
| Value | $4.09M | $132.8K | $2.52M | −$1.43M (−36.2%) |
2 institutions that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so the changes leave them out.
New holders (6)
Institutions that held Brainstorm Cell Therapeutics Inc. at the end of Q3 2024 but not at the end of Q2 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| BlackRock, Inc. | 377,611 | $87.0K | 0.00% |
| XTX Topco Ltd | 53,088 | $12.2K | 0.00% |
| Tru Independence Asset Management 2, LLC | 44,000 | $10.1K | 0.01% |
| Jump Financial, LLC | 10,995 | $2.53K | 0.00% |
| Reuter James Wealth Management, LLC | 1,034 | $238 | 0.00% |
| Bogart Wealth, LLC | 34 | $8 | 0.00% |
Sold out (14)
Institutions that held Brainstorm Cell Therapeutics Inc. at the end of Q2 2024 and filed for Q3 2024 without it.
| Institution | Shares, Q2 2024 | Value, Q2 2024 |
|---|---|---|
| Ikarian Capital, LLC | 90,242 | $30.5K |
| Virtu Financial LLC | 49,586 | $17.0K |
| Sanctuary Advisors, LLC | 17,210 | $9.20K |
| Jane Street Group, LLC | 19,834 | $6.71K |
| Professional Financial Advisors, LLC | 17,279 | $5.85K |
| First Affirmative Financial Network | 14,293 | $4.84K |
| LPL Financial LLC | 10,052 | $3.40K |
| EverSource Wealth Advisors, LLC | 2,128 | $728 |
| VisionPoint Advisory Group, LLC | 1,944 | $658 |
| Cranbrook Wealth Management, LLC | 1,000 | $339 |
| BNP Paribas Arbitrage, SA | 364 | $123 |
| Mark Sheptoff Financial Planning, LLC | 100 | $34 |
| Caldwell Sutter Capital, Inc. | 157,009 | $0 |
| Royal Bank of Canada | 529 | $0 |
Not filed for Q3 2024 yet (2)
Institutions that held Brainstorm Cell Therapeutics Inc. at the end of Q2 2024 and haven't filed a 13F for Q3 2024. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2024 | Value, Q2 2024 |
|---|---|---|
| BlackRock Inc. | 386,414 | $130.8K |
| Institutional & Family Asset Management, LLC | 6,000 | $2.03K |